Does LEUPROLIDE Cause Coronary artery disease? 75 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Coronary artery disease have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.1% of all adverse event reports for LEUPROLIDE.
75
Reports of Coronary artery disease with LEUPROLIDE
0.1%
of all LEUPROLIDE reports
13
Deaths
37
Hospitalizations
How Dangerous Is Coronary artery disease From LEUPROLIDE?
Of the 75 reports, 13 (17.3%) resulted in death, 37 (49.3%) required hospitalization, and 2 (2.7%) were considered life-threatening.
Is Coronary artery disease Listed in the Official Label?
Yes, Coronary artery disease is listed as a known adverse reaction in the official FDA drug label for LEUPROLIDE.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Coronary artery disease?
ROSIGLITAZONE (4,982)
ASPIRIN (807)
METFORMIN\ROSIGLITAZONE (738)
AVANDIA (667)
ROSUVASTATIN (508)
TESTOSTERONE (453)
PANTOPRAZOLE (422)
CLOPIDOGREL BISULFATE (402)
ALBUTEROL (391)
ADALIMUMAB (353)
Which LEUPROLIDE Alternatives Have Lower Coronary artery disease Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM